ADRENOCORTICAL CARCINOMA
Clinical trials for ADRENOCORTICAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADRENOCORTICAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADRENOCORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: Two-Drug combo enters key trial
Disease control OngoingThis study is testing whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, can help control advanced, rare cancers of the urinary and reproductive systems. It is for adults whose cancer has spread and who have few other treatment options. The main goal is t…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for Tough-to-Treat adrenal cancer
Disease control OngoingThis study is testing whether a combination of two drugs, pembrolizumab (given by IV) and lenvatinib (taken as a pill), can help control advanced adrenal cancer that has continued to grow despite standard chemotherapy. It will involve about 30 adult patients who have already trie…
Matched conditions: ADRENOCORTICAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Center, Korea • Aim: Disease control
Last updated Mar 10, 2026 12:54 UTC
-
Scientists dig through old records to crack code of rare, deadly cancer
Knowledge-focused OngoingThis study aims to better understand adrenocortical cancer, a rare and aggressive disease, by looking back at the medical records of about 1,000 patients. Researchers will analyze how long patients lived and how they responded to different treatments, hoping to find patterns that…
Matched conditions: ADRENOCORTICAL CARCINOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC